FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

109053000: Octreotide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173588012 Octreotide en Synonym Active Entire term case insensitive SNOMED CT core module
607669011 Octreotide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide Is a Somatostatin false Inferred relationship Existential restriction modifier
Octreotide Is a Allergen class false Inferred relationship Existential restriction modifier
Octreotide Is a Drug allergen false Inferred relationship Existential restriction modifier
Octreotide Is a Somatostatin analog true Inferred relationship Existential restriction modifier
Octreotide Is a Cyclic peptide true Inferred relationship Existential restriction modifier
Octreotide Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Mayne Pharma Plc) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Lexon (UK) Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Mawdsley-Brooks & Company Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Doncaster Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Doncaster Pharmaceuticals Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Kent Pharma (UK) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Teva UK Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Teva UK Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Teva UK Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sandoz Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sandoz Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sandoz Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules (Sandoz Ltd) 5 ampoule Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (A A H Pharmaceuticals Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection pre-filled syringes (Alliance Healthcare (Distribution) Ltd) 5 pre-filled disposable injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 5 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Alliance Healthcare (Distribution) Ltd) 1 vial Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sandoz Ltd) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules (Sandoz Ltd) 5 ampoule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier

Start Previous Page 4 of 4


This concept is not in any reference sets

Back to Start